Cholesterol 7α-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells

Journal of Lipid Research

Volumn 38, Issue 7, 1997, Pages 1445-1453

  Dueland, Svein ^b,c   France, Dennis ^b,d   Wang, Shui Long ^a   Trawick, John D ^a   Davis, Roger A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Sandoz Pharma Ltd   (Switzerland)

Author keywords

7 hydroxylase; Atherosclerosis; HDL; LCAT

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; CHOLIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BILE ACID METABOLISM; CHOLESTEROL METABOLISM; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; GENETIC SUSCEPTIBILITY; HEPATOMA CELL; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ARTERIOSCLEROSIS; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL CULTURE; CHOLESTEROL INTAKE; GENE EXPRESSION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; RAT;

ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLIC ACID; CHOLIC ACIDS; FEMALE; GENE EXPRESSION; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030610558     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lusis, A. J., B. A. Taylor, R. W. Wangestein, and R. L. LeBoeuf. 1983. Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins. J. Biol. Chem. 258: 5071-5078.
2. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57: 65-73.
3. Paigen, B., D. Mitchell, K. Reue, A. Morrow, A. J. Lusis, and R. C. LeBoeuf. 1987. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA. 84: 3763-3767.
4. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
5. Paigen, B., M. N. Nesbitt, D. Mitchell, D. Albee, and R. C. LeBoeuf. 1989. Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Genetics. 122: 163-168.
6. Stewart-Phillips, J. L., J. Lough, and E. Skamene. 1989. Ath-3, a new gene for atherosclerosis in the mouse. Clin. Invest. Med. 12: 121-126.
7. Ruben, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
8. LeBoeuf, R. C., M. H. Doolittle, A. Montcalm, D. C. Martin, K. Reue, and A. J. Lusis. 1990. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. J. Lipid Res. 31: 91-101.
9. Nishina, P. M., J. Verstuyft, and B. Paigen. 1990. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31: 859-869.
10. Dueland, S., J. Drisko, L. Graf, D. Machleder, A. J. Lusis, and R. A. Davis. 1993. Effect of dietary cholesterol and taurocholate on cholesterol-7α-hydroxylase and hepatic LDL receptors in inbred mice. J. Lipid Res. 34: 923-931.
11. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
12. 14C-cholesterol excreted in bile and feces. Proc. Soc. Exp. Biol. Med. 81: 720-724.
13. Schwartz, C. C., L. A. Zech, J. M. Vanden Broek, and P. S. Cooper. 1993. Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate. J. Clin. Invest. 91: 923-938.
14. Rinninger, F., and R. C. Pittman. 1989. Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by HepG2 cells. J Biol Chem. 264: 6111-6118.
15. Goldberg, D. I., W. F. Beltz, and R. C. Pittman. 1991. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. J. Clin. Invest. 87: 331-346.
16. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 271: 518-520.
17. Davis, R. A., P. M. Hyde, J. C. Kuan, M. M. Malone-McNeal, and S. J. Archambault. 1983. Bile acid secretion by cultured rat hepatocytes. Regulation by cholesterol availability. J. Biol. Chem. 258: 3661-3667.
18. Mackinnon, A. M., C. A. Drevon, T. M. Sand, and R. A. Davis. 1987. Regulation of bile acid synthesis in cultured rat hepatocytes: stimulation by apoE-rich high density lipoproteins. J Lipid Res. 28: 847-855.
19. Junker, L. H., and R. A. Davis. 1989. Receptor-mediated uptake of low density lipoprotein stimulates bile acid synthesis by cultured rat hepatocytes. J. Lipid Res. 30: 1933-1941.
20. Attie, A. D., R. C. Pittman, and D. Steinberg. 1982. Hepatic catabolism of low density lipoprotein: mechanisms and metabolic consequences. Hepatology. 2: 269-281.
21. Dietschy, J. M., S. D. Turley, and D. K. Spady. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34: 1637-1659.
22. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J. Clin. Invest. 72: 743-747.
23. Clifton, P. M., M. Kestin, M. Abbey, M. Drysdale, and P. J. Nestel. 1990. Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis. 10: 394-401.
24. Swanson, M. E., T. E., Hughes, I. S. Denny, D. S. France, J. Paterniti, J. R., C. Tapparelli, P. Gfeller, and K. Burki. 1992. High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res. 1: 142-147.
25. Davis, R. A., P. Helgerud, S. Dueland, and C. A. Drevon. 1982. Evidence that reverse cholesterol transport occurs in vivo and requires lecithin-cholesterol acyltransferase. Biochim. Biophys. Acta. 689: 410-414.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
27. Leighton, J. K., S. Dueland, M. S. Straka, J. Trawick, and R. A. Davis. 1991. Activation of the silent endogenous cholesterol-7-alpha-hydroxylase gene in rat hepatoma cells: a new complementation group having resistance to 25-hydroxycholesterol. Mol. Cell. Biol. 11: 2049-2056.
28. Trawick, J. D., K. D. Lewis, S. Dueland, G. L. Moore, F. R. Simon, and R. A. Davis. 1996. Rat hepatoma L35 cells, a liver-differentiated cell line, display resistance to bile acid repression of cholesterol 7α-hydroxylase. J. Lipid Res. 37: 588-598.
29. Warden, C. H., C. A. Langer, J. I. Gordon, B. A. Taylor, J. W. McLean, and A. J. Lusis. 1989. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin:cholesterol acyltransferase gene. J. Biol. Chem. 264: 21573-21581.
30. Fielding, C., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 26: 211-228.
31. Mehlum, A., and H. Prydz. 1994. Mice transgenic for the human LCAT gene. Clin. Genetics. 46 (1 Spec No): 92.
32. Vaisman, B. L., H. G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. J. Hoyt, S. M. Marcovina, J. J. Albers, J. M. Hoeg, H. J. Brewer, and F. S. Santamarina. 1995. Overexpression of human lecithin:cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
33. Chao, Y. S., C. B. Pickett, T. T. Yamin, L. S. Guo, A. W. Alberts, and P. A. Kroon 1985. Phenobarbital induces rat liver apolipoprotein A-I mRNA. Mol. Pharmacol. 27: 394-398.
34. Sudjana-Sugiaman, E., G. Eggertsen, and I. Björkhem 1994. Stimulation of HMG-CoA reductase as a consequence of phenobarbital-induced primary stimulation of cholesterol 7α-hydroxylase in rat liver. J. Lipid Res. 35: 319-327.
35. Myant, N. B., and K. A. Mitropoulos. 1977. 7-α-Hydroxylase. J. Lipid Res. 18: 135-153.
36. Einarsson, K., S. Ericsson, S. Ewerth, E. Reihner, M. Rudling, D. Stahlberg, and B. Angelin. 1991. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur. J. Clin. Pharmacol. 40, Suppl 1: S53-S58.
37. Staels, B., A. Van Tol, J. C. Fruchart, and J. Auwerx. 1996. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Isr. J. Med. Sci. 32: 490-498.
38. Buchwald, H., R. L. Varco, J. P. Matts, J. M. Long, L. L. Fitch, G. S. Campbell, M. B. Pearce, A. E. A. Yellin, and R. D. Smink, Jr., et al. 1990. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N. Engl. J. Med. 323: 946-955.